Vectura logo

VEC - Vectura News Story

86.3p -3.0  -3.3%

Last Trade - 18/10/19

Sector
Healthcare
Size
Mid Cap
Market Cap £531.0m
Enterprise Value £433.4m
Revenue £172.3m
Position in Universe 536th / 1855

Drugmaker Vectura CEO James Ward-Lilley to step down

Mon 10th June, 2019 7:23am
June 10 (Reuters) - British drugmaker Vectura Group Plc's
 VEC.L  chief executive officer, James Ward-Lilley, will step
down by the end of this month, the company said on Monday.
    Ward-Lilley, who took on the top position in September 2015,
will be replaced by Chief Financial Officer Paul Fry on an
interim basis as the company starts looking for a new CEO,
Vectura said.

 (Reporting by Muvija M in Bengaluru
Editing by Saumyadeb Chakrabarty)
 ((Muvija.M@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6749 3638; Reuters Messaging:
muvija.m.thomsonreuters.com@reuters.net))
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.